Article Text

PDF
Effectiveness of SAG1 oral vaccine for the long-term protection of red foxes (Vulpes vulpes) against rabies
  1. M. Artois, DVM, PhD1,
  2. F. Cliquet, PhD1,
  3. J. Barrat, DVM1 and
  4. C. L. Schumacher, DVM, PhD2
  1. 1 CNEVA Nancy, Laboratoire d'études sur la rage et la pathologie des animaux sauvages, Domaine de Pixérécourt, BP 9 Malzéville, France
  2. 2 Laboratoires VIRBAC, BP 27 06511 CARROS, Cédex, France

Abstract

Three groups of 10 foxes were vaccinated by the direct oral instillation of 2 ml of SAG1 rabies virus vaccine containing 106 MICLD50 (107 TCID50/ml) infectious viral particles/ml. SAG1 is a natural variant of the attenuated rabies vaccine strain SAD Bern and was selected in the presence of monoclonal antibodies. The strain is devoid of residual pathogenicity for the fox and the highly susceptible adult laboratory mouse by the oral, intramuscular and intracerebral routes. The foxes were challenged six, 12 and 18 months later with a virulent vulpine street rabies virus (GS 7-1-1). They all survived, whereas seven of eight unvaccinated control foxes died.

    Statistics from Altmetric.com

      Request permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.